BRPI0812346A2 - Toxina netb clostridial - Google Patents

Toxina netb clostridial

Info

Publication number
BRPI0812346A2
BRPI0812346A2 BRPI0812346-2A2A BRPI0812346A BRPI0812346A2 BR PI0812346 A2 BRPI0812346 A2 BR PI0812346A2 BR PI0812346 A BRPI0812346 A BR PI0812346A BR PI0812346 A2 BRPI0812346 A2 BR PI0812346A2
Authority
BR
Brazil
Prior art keywords
clostridial
netb toxin
netb
toxin
clostridial netb
Prior art date
Application number
BRPI0812346-2A2A
Other languages
English (en)
Inventor
Robert John Moore
Julian Ian Rood
Anthony Leslie Keyburn
Original Assignee
Australian Poultry Crc Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40093085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0812346(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Australian Poultry Crc Pty Ltd filed Critical Australian Poultry Crc Pty Ltd
Publication of BRPI0812346A2 publication Critical patent/BRPI0812346A2/pt
Publication of BRPI0812346B1 publication Critical patent/BRPI0812346B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0812346A 2007-06-08 2008-06-06 célula hospedeira, método para a produção de um polipeptídeo isolado, composição, vacinas, método de atenuação da virulência de uma bactéria, método para determinar se um indivíduo foi exposto a um patógeno e uso da célula hospedeira, das vacinas ou da bactéria BRPI0812346B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94285807P 2007-06-08 2007-06-08
PCT/AU2008/000813 WO2008148166A1 (en) 2007-06-08 2008-06-06 Clostridial toxin netb

Publications (2)

Publication Number Publication Date
BRPI0812346A2 true BRPI0812346A2 (pt) 2015-01-27
BRPI0812346B1 BRPI0812346B1 (pt) 2019-01-22

Family

ID=40093085

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812346A BRPI0812346B1 (pt) 2007-06-08 2008-06-06 célula hospedeira, método para a produção de um polipeptídeo isolado, composição, vacinas, método de atenuação da virulência de uma bactéria, método para determinar se um indivíduo foi exposto a um patógeno e uso da célula hospedeira, das vacinas ou da bactéria

Country Status (14)

Country Link
US (1) US8263088B2 (pt)
EP (2) EP2164862B1 (pt)
JP (2) JP5901115B2 (pt)
CN (1) CN101903399B (pt)
AU (1) AU2008258277B2 (pt)
BR (1) BRPI0812346B1 (pt)
CA (1) CA2689302C (pt)
ES (1) ES2550685T3 (pt)
HU (1) HUE025717T2 (pt)
MX (1) MX2009012924A (pt)
PL (1) PL2164862T3 (pt)
PT (1) PT2164862E (pt)
RU (1) RU2474587C2 (pt)
WO (1) WO2008148166A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32403A (es) * 2009-01-30 2010-08-31 Intervet Int Bv Un polipeptido de clostridium chauvoei, adn que codifica el polipeptido y una vacuna que comprende el polipeptido
WO2011113801A1 (en) * 2010-03-16 2011-09-22 Universiteit Gent Use of clostridium perfringens strain 23 to protect against necrotic enteritis
GB201118394D0 (en) 2011-10-25 2011-12-07 Univ Exeter Vaccine
US10174086B2 (en) 2011-10-25 2019-01-08 University Of Exeter Vaccine
KR101293667B1 (ko) 2011-11-16 2013-08-07 대한민국 닭의 괴사성 장염을 예방하는 백신 조성물
AU2013239465B2 (en) 2012-03-29 2017-04-20 One Health Ventures Limited Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
WO2013173910A1 (en) * 2012-05-23 2013-11-28 University Of Guelph A novel toxin in type a clostridium perfringens
GB201322463D0 (en) * 2013-12-18 2014-02-05 Univ Exeter Composition
US9505810B2 (en) 2014-08-22 2016-11-29 University Of Guelph Toxins in type A Clostridium perfringens
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
CA3063287A1 (en) * 2017-05-12 2018-11-15 Evonik Operations Gmbh Method for detecting c. perfringens induced diseases in animals
WO2018206690A1 (en) * 2017-05-12 2018-11-15 Evonik Degussa Gmbh Method for detecting c. perfringens induced diseases in animals
JP2020527051A (ja) * 2017-05-31 2020-09-03 ハー マジェスティー ザ クイーン イン ライト オブ カナダ アズ リプレゼンティッド バイ ザ ミニスター オブ アグリカルチャー アンド アグリ−フードＨｅｒ Ｍａｊｅｓｔｙ Ｔｈｅ Ｑｕｅｅｎ Ｉｎ Ｒｉｇｈｔ Ｏｆ Ｃａｎａｄａ Ａｓ Ｒｅｐｒｅｓｅｎｔｅｄ Ｂｙ Ｔｈｅ Ｍｉｎｉｓｔｅｒ Ｏｆ Ａｇｒｉｃｕｌｔｕｒｅ Ａｎｄ Ａｇｒｉ−Ｆｏｏｄ 家禽における壊疽性腸炎に対するワクチン
CN112166198A (zh) * 2018-05-29 2021-01-01 赢创运营有限公司 监测动物种群中病原体负荷的体外方法
DK3807421T3 (da) * 2018-06-15 2023-12-11 Evonik Operations Gmbh Fremgangsmåde til tidlig påvisning af et udbrud af nekrotisk enteritis i en fuglepopulation
EP3818079A4 (en) * 2018-07-05 2022-04-06 Novobind Livestock Therapeutics Inc. ANTIBODIES AGAINST POULTRY PATHOGENS AND THEIR USE
KR102207354B1 (ko) * 2019-09-02 2021-01-27 (주)제이비바이오텍 CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 닭의 괴사성장염 백신
US11381146B2 (en) 2019-09-04 2022-07-05 Nti Ag Drive device having a tubular linear motor and a stainless steel casing
CN113717292B (zh) * 2021-09-27 2023-04-21 华中农业大学 一种针对鸡坏死性肠炎的融合蛋白疫苗及其制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
AU7360087A (en) 1986-04-30 1987-11-24 Boyce Thompson Institute For Plant Research Inc. Electric field mediated dna transformation of plant cells and organelles
US5177010A (en) 1986-06-30 1993-01-05 University Of Toledo Process for transforming corn and the products thereof
US4903635A (en) 1986-07-02 1990-02-27 Embrex, Inc. High speed automated injection system for avian embryos
SE455438B (sv) 1986-11-24 1988-07-11 Aga Ab Sett att senka en brennares flamtemperatur samt brennare med munstycken for oxygen resp brensle
US5004863B2 (en) 1986-12-03 2000-10-17 Agracetus Genetic engineering of cotton plants and lines
CA2062795A1 (en) 1989-06-29 1990-12-30 Michael W. Fanger Bispecific reagents for aids therapy
US5141131A (en) 1989-06-30 1992-08-25 Dowelanco Method and apparatus for the acceleration of a propellable matter
US5056464A (en) 1990-01-18 1991-10-15 Embrex, Inc. Automated injection system for avian embryos with advanced fluid delivery system
EP0955371B1 (en) 1990-11-23 2006-02-22 Bayer BioScience N.V. Process for transforming monocotyledonous plants
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
US5136979A (en) 1991-09-25 1992-08-11 Embrex, Inc. Modular injection system for avian embryos
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
JPH07505531A (ja) 1992-04-15 1995-06-22 プラント・ジェネティック・システムズ・エヌ・ブイ 単子葉植物細胞の形質転換法
DK0639640T3 (da) 1993-07-30 2001-01-02 Akzo Nobel Nv Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
EP0740704A1 (en) 1994-01-27 1996-11-06 University Of Massachusetts Medical Center Immunization by inoculation of dna transcription unit
DK0750907T3 (da) * 1995-06-30 2002-07-08 American Cyanamid Co Stabile vaccinepræparater til parenteral administrering, en fremgangsmåde til deres anvendelse og en fremgangsmåde til deres fremstilling
US5792294A (en) 1995-11-16 1998-08-11 Otis Elevator Company Method of replacing sheave liner
US5939400A (en) 1996-02-26 1999-08-17 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for induction of suppressive T cell response
GB9605222D0 (en) * 1996-03-12 1996-05-15 Secr Defence Clostridium perfringens epsilon toxin vaccines
AU3210997A (en) 1996-05-24 1997-12-09 University Of Maryland At Baltimore Dna vaccines for eliciting a mucosal immune response
PT892054E (pt) * 1997-06-20 2007-02-28 Intervet Int Bv Vacina de clostridium perfringens
WO1999019472A1 (en) 1997-10-16 1999-04-22 University Of Georgia Research Foundation, Inc. Vectors comprising a magnum-specific promoter for avian transgenesis
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
EP1499191B1 (en) * 2002-04-15 2012-05-09 Washington University in St. Louis Regulated attenuation of live vaccines to enhance cross protective immunogenicity
US20040101531A1 (en) * 2002-04-16 2004-05-27 Roy Curtiss Immunogenic compositions and vaccines comprising carrier bacteria that secrete antigens
BRPI0411526A (pt) * 2003-06-18 2006-08-01 Genelux Corp vìrus de vaccinia e outros microrganismos recombinates modificados e usos dos mesmos
US7617795B2 (en) 2004-10-13 2009-11-17 Embrex, Inc. Methods and apparatus for injecting and sampling material through avian egg membranes
CN101273133A (zh) 2005-08-30 2008-09-24 联邦科学工业研究组织 生物活性多肽的细菌传送
CN101460192A (zh) * 2006-03-30 2009-06-17 恩布里克斯公司 家禽疫苗接种的方法和组合物
WO2009046449A1 (en) * 2007-10-05 2009-04-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens

Also Published As

Publication number Publication date
JP2010529838A (ja) 2010-09-02
US8263088B2 (en) 2012-09-11
BRPI0812346B1 (pt) 2019-01-22
JP2014221046A (ja) 2014-11-27
RU2009149378A (ru) 2011-07-20
EP2164862A4 (en) 2011-11-02
MX2009012924A (es) 2010-03-25
CA2689302A1 (en) 2008-12-11
US20100291131A1 (en) 2010-11-18
PL2164862T3 (pl) 2015-12-31
EP2164862B1 (en) 2015-07-22
PT2164862E (pt) 2015-10-29
AU2008258277B2 (en) 2012-07-12
CN101903399B (zh) 2014-09-10
HUE025717T2 (en) 2016-04-28
WO2008148166A1 (en) 2008-12-11
AU2008258277A1 (en) 2008-12-11
ES2550685T3 (es) 2015-11-11
RU2474587C2 (ru) 2013-02-10
EP2980100A1 (en) 2016-02-03
CA2689302C (en) 2015-08-25
EP2164862A1 (en) 2010-03-24
CN101903399A (zh) 2010-12-01
JP5901115B2 (ja) 2016-04-06

Similar Documents

Publication Publication Date Title
BRPI0812346A2 (pt) Toxina netb clostridial
BRPI0816771A2 (pt) Espaçador interespinhal
DK3332805T3 (da) Injicerbare botulinumtoksinformuleringer
FI20085597A0 (fi) Tiedon haku
DE602008003603D1 (de) Speicherplattensystem
DK2650003T3 (da) Nedbrydelige clostridiumtoksiner
FI20070177A (fi) Turvajärjestely
DE602008001144D1 (de) Kogenerationssystem
DE602008002287D1 (de) Aufzeichnungsgerät
BRPI0819600A2 (pt) Servoválvula.
DE602008002037D1 (de) Aufzeichnungsgerät
DK2133416T3 (da) Rekombinant mikroorganisme
DE112008002850A5 (de) Rohrleitung
FI7604U1 (fi) Tuntoelin
FR2920806B1 (fr) Cadenas.
ES1065818Y (es) Picaporte magnetico
FI20075839A (fi) Tietojärjestelmä
ITCO20060012A1 (it) Anti - urto
SE0702505L (sv) Smart dust
FI20085818A0 (fi) Informaatiojärjestelmä
FI20085421A0 (fi) Tietojärjestelmä
FI20070088A0 (fi) Haaviston luomu-arkku
ES1066176Y (es) Mueble publicitario
UA17262S (uk) Цінник
UA16352S (uk) Музичний автомат

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/01/2019, OBSERVADAS AS CONDICOES LEGAIS.